Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis

doi:10.4254/wjh.124709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(4)

(3)

(0)

(38)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. Oct 27, 2026; 18(10): 124709
Published online Oct 27, 2026. doi: 10.4254/wjh.124709

Table 9 Extended multivariable models for waiting-list death

Covariate	csHR (95%CI)	sHR (95%CI)
HDV infection	1.90 (1.30-2.77)^b	1.14 (0.84-1.55)
Age (year)	1.01 (0.99-1.03)	1.00 (0.99-1.02)
Female sex	0.60 (0.41-0.88)^b	0.63 (0.46-0.86)^b
MELD-Na per point	1.07 (1.03-1.11)^b	1.03 (1.00-1.07)
Era II vs I	0.86 (0.57-1.31)	0.75 (0.53-1.08)
Albumin (per g/L)	1.01 (0.97-1.04)	0.99 (0.97-1.02)
Ascites	1.50 (1.02-2.21)^a	1.31 (0.95-1.80)
Hepatocellular carcinoma	2.38 (1.48-3.84)^b	1.33 (0.91-1.93)
Antiviral therapy	0.92 (0.48-1.76)	0.88 (0.49-1.57)

^aP < 0.05.

^bP < 0.01.

csHR: Cause-specific hazard ratio; sHR: Subdistribution hazard ratio; MELD-Na: Model for end-stage liver disease-sodium; HDV: Hepatitis delta virus.

Full Size Table

Citation: Peltec A, Buga D, Hotineanu A, Wedemeyer H. Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis. World J Hepatol 2026; 18(10): 124709
URL: https://www.wjgnet.com/1948-5182/full/v18/i10/124709.htm
DOI: https://dx.doi.org/10.4254/wjh.124709

Peltec A, Buga D, Hotineanu A, Wedemeyer H. Impact of hepatitis delta virus infection on waiting list outcomes: A competing-risks analysis. World J Hepatol 2026; 18(10): 124709 [DOI: 10.4254/wjh.124709]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.